May 13 (Reuters) - Lexicon Pharmaceuticals Inc LXRX.O:
LEXICON PHARMACEUTICALS Q1 OPERATING INCOME USD -25.679 MILLION
LEXICON PHARMACEUTICALS Q1 OPERATING EXPENSES USD 26.941 MILLION
LEXICON PHARMACEUTICALS Q1 NET INCOME USD -25.295 MILLION
LEXICON PHARMACEUTICALS Q1 BASIC EPS USD -0.07
LEXICON PHARMACEUTICALS INC: ON TRACK FOR NEXT STEPS IN PILAVAPADIN'S DEVELOPMENT, INCLUDING OUR END OF PHASE 2 MEETING WITH FDA
Source text: ID:nGNXbnn131
Further company coverage: LXRX.O
((Reuters.Briefs@thomsonreuters.com;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。